In order to identify more predictive factors from pathological evaluation to facilitate the clinical management, we performed this systematic review and meta-analysis of published papers to explore these specific features and their impacts on the BCR of prostate cancer after RP. The gene discussed is BCR; the disease is Familial prostate cancer.